Hepatocellular carcinoma: Difference between revisions
Line 35: | Line 35: | ||
==Treatment== | ==Treatment== | ||
[[Hepatocellular carcinoma medical therapy|Medical Therapy]] | [[Hepatocellular carcinoma surgery|Surgery]] | [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | [[Hepatocellular carcinoma medical therapy|Medical Therapy]] | [[Hepatocellular carcinoma surgery|Surgery]] | [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | [[Hepatocellular carcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hepatocellular carcinoma future or investigational therapies|Future or Investigational Therapies]] | ||
Line 41: | Line 41: | ||
{{MedCondContrAbs|MedCond = Hepatocellular carcinoma|Drospirenone and Ethinyl estradiol|Norethindrone acetate and Ethinyl estradiol|Norgestimate and Ethinyl estradiol|Norgestrel and Ethinyl estradiol|Hydroxyprogesterone caproate}} | {{MedCondContrAbs|MedCond = Hepatocellular carcinoma|Drospirenone and Ethinyl estradiol|Norethindrone acetate and Ethinyl estradiol|Norgestimate and Ethinyl estradiol|Norgestrel and Ethinyl estradiol|Hydroxyprogesterone caproate}} | ||
==Resources== | ==Resources== |
Revision as of 14:42, 10 September 2015
Hepatocellular carcinoma | |
![]() | |
---|---|
Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein |
Hepatocellular carcinoma Microchapters |
Differentiating Hepatocellular carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma; hepatic cancer
Overview
Historical perspective
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical Therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Contraindicated medications
Hepatocellular carcinoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol
- Hydroxyprogesterone caproate
Resources
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology